0001), less than high school education P less then .0001), high school education (P less then .001), and perceived great risk of drugs (P less then .0001). Conclusions LSD use in the US jumped 56.4% from 2015 to 2018. Results from the present study can inform prevention and harm reduction efforts (e.g., co-morbid substance use interventions, health messaging).Background Previous studies have postulated that four structural compartments may be differentiated in hair surface protein domain, water-accessible protein domain, water-inaccessible protein domain, and melanin. Drugs contained in blood, sweat, sebum, and environment would be deposited in the first two domains, with primarily drugs in blood being incorporated in the latter two domains during hair synthesis. Drugs in the first two domains would be removed by washing procedures. Use of enzymatic extraction procedures and evaluation of hair for damage from harsh cosmetic treatments might help to separately identify and quantify the drugs incorporated in the second two domains. Aims a) Development of an UPLC-MS/MS method for the simultaneous quantification of the following 19 antipsychotic drugs and metabolites in hair amisulpride, aripiprazole, chlorpromazine, clotiapine, clozapine, desmethylclozapine, desmethylolanzapine, haloperidol, norchlorpromazine, 7-OH-quetiapine, 9-OH-risperidone, olanzapine, pimozine, in and water-inaccessible protein fraction of hair, separately. No correlation between the prescribed dose and the concentrations found in the protein and melanin domains were observed. The results show that hair melanin would have a much higher affinity for the antipsychotic medications than do hair proteins, being influenced mainly by biochemical individuality effects and less by hair colour. Future studies would be of interest using the proposed extraction method applied to hair of different colours.COVID-19 pandemic has changed the risk-benefit balance for cardiopulmonary resuscitation.•Cardiopulmonary resuscitation is a highly aerosol-generating procedure.•Literature is inadequate to direct clinicians towards cardiopulmonary resuscitation in COVID-19 patient.Objective A systematic review of research assessing factors associated with inpatient psychiatric readmission of children and adolescents. Methods In accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), we searched 8 databases (1994-2018) to identify relevant articles on factors associated with youth psychiatric readmission. Selected articles addressed one or more factors associated with psychiatric readmission for children and adolescents (≤21 years of age) admitted to a psychiatric hospital in the United States for a primary mental health diagnosis. Two authors independently reviewed article abstracts, titles, and text. Results Of 7903 retrieved articles, 30 studies met inclusion criteria. Analyzed variables were categorized according to child demographic and clinical characteristics; family, provider, and community characteristics; and treatment and aftercare characteristics. Available studies were markedly heterogeneous in methodology and outcomes. Factors associated with an increased risk of readmission included greater symptom severity, clinical diagnoses such as psychosis and affective disorders, suicidal behavior and self-injury, poor family functioning, and longer lengths of index hospital stay. Conclusions Controlled trials of interventions to improve care and reduce recidivism for psychiatrically hospitalized youth are needed. read more Future research will benefit from a guiding theoretical framework, more representative samples, and standardized exposure/outcome measures.The number of older people who experience marital break-up has increased in many Western countries. However, limited empirical attention has been given to the study of the consequences of later-life divorce or separation. Previous studies on gray divorce are often cross-sectional and tend to capture a mix of short- and long-term effects of divorce and possibly selection effects into divorce. Drawing on data from nine waves of the UK Household Longitudinal Study (2009/2010-2017/2018), we analyze the effect of marital break-up on the mental health of 909 adults aged 50 or over to test the crisis model and the chronic strain model of divorce. We use fixed effects linear regression models to account for time-invariant confounders and distinguish between pre- and post-divorce effects. Our results indicate that older adults’ depressive symptoms (GHQ) increase in the years before and upon union dissolution. After separation, depressive symptoms decrease and return to approximately previous baseline levels. Our analyses on heterogeneity in the effects of gray divorce show that post-divorce adjustment is faster for childless adults than for parents. We find no evidence that adjustment after gray divorce is slower for women than for men, or for persons who already experienced a prior union dissolution than for those who separate for the first time. The results are consistent with the crisis model of divorce but in contrast with the chronic strain model of divorce. Older adults are able to adjust to marital break-up, and their fertility histories tend to moderate the negative effect of later-life divorce on mental health.There is a growing understanding as science evolves that different cancer types require different approaches to treatment evaluation, especially in the metastatic stages. The introduction of new metastatic breast cancer (MBC) treatments may be hindered by several elements, including the availability of relevant evidence related to disease-specific outcomes, the benefit assessment process around the evaluation of the clinical benefit and the patients’ need of new treatments. The Steering Committee (SC) found that not all issues relevant to MBC patients are consistently considered in the current benefit assessment process of new treatments. Among these are overall survival, time-to-event endpoints (e.g. progression-free survival), patients’ priorities, burden of disease, MBC-specific quality of life, value in delaying chemotherapy, route of administration, side effects and toxicities, treatment adherence and the benefit of real-world evidence. This paper calls on decision makers to (1) Include MBC-specific patient priorities and outcomes in the overall benefit assessments of new MBC treatments; (2) Enhance multi-stakeholder collaboration in order to improve MBC patient outcomes.